Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
- PMID: 31377881
- PMCID: PMC7339114
- DOI: 10.1007/s11934-019-0917-1
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
Abstract
Purpose of review: The purpose of this review is to summarize the role and significance of inflammation as a putative additional factor contributing to lower urinary tract symptoms and the progression of benign prostatic hyperplasia. We review (1) the histologic definition of prostatic inflammation and its prevalence, (2) the effects inflammation in the prostate including on risk of acute urinary retention, and (3) the effects of systemic inflammation on the prostate and on voiding.
Recent findings: Inflammation is a highly prevalent finding in the prostate, both on a histological and biochemical level. Men with inflammation have higher IPSS scores and increased prostate size; however, these differences appear to be imperceptibly small. Men with inflammation do experience a significantly increased risk of developing acute urinary retention, an event that is associated with significant morbidity. Recently, attempts have been made to identify more specific biochemical markers of local inflammation, and to identify regional patterns of inflamed tissue within the prostate which may be associated with higher IPSS scores, accelerated progression, and AUR. The effects of systemic inflammatory states, most notably MetS, and their role in LUTS have also been examined. Inflammation is a common finding in prostates of aging men, but its contribution to lower urinary tract symptoms and benign prostatic hyperplasia progression appears to be small when considered as a clinically relevant entity. Advances in the understanding of different forms of inflammation, and their impact when experienced in different locations within the prostate, may refine this knowledge. Systemic inflammation affects voiding, including in the absence of a prostate, but again significant effects of systemic inflammation on the prostate itself are also difficult to demonstrate. Prostatic inflammation is associated with a significantly increased risk of acute urinary retention.
Keywords: Benign prostate hyperplasia; Inflammation; Lower urinary tract symptoms; Prostatic inflammation.
Similar articles
-
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.J Urol. 2016 Nov;196(5):1493-1498. doi: 10.1016/j.juro.2016.06.090. Epub 2016 Jul 1. J Urol. 2016. PMID: 27378134 Clinical Trial.
-
Inflammation, Voiding and Benign Prostatic Hyperplasia Progression.J Urol. 2019 May;201(5):868-870. doi: 10.1097/JU.0000000000000049. J Urol. 2019. PMID: 30694937 Free PMC article. No abstract available.
-
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).BJU Int. 2013 Aug;112(4):432-41. doi: 10.1111/bju.12118. Epub 2013 Apr 12. BJU Int. 2013. PMID: 23650937 Review.
-
Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.Prostate. 2018 Jul;78(10):743-752. doi: 10.1002/pros.23518. Epub 2018 Apr 2. Prostate. 2018. PMID: 29608020
-
Correlation between benign prostatic hyperplasia and inflammation.Curr Opin Urol. 2013 Jan;23(1):5-10. doi: 10.1097/MOU.0b013e32835abd4a. Curr Opin Urol. 2013. PMID: 23159991 Review.
Cited by
-
Increased COX-1 expression in benign prostate epithelial cells is triggered by mitochondrial dysfunction.Am J Clin Exp Urol. 2022 Aug 15;10(4):234-245. eCollection 2022. Am J Clin Exp Urol. 2022. PMID: 36051613 Free PMC article.
-
E-cadherin expression is inversely correlated with aging and inflammation in the prostate.Am J Clin Exp Urol. 2021 Feb 15;9(1):140-149. eCollection 2021. Am J Clin Exp Urol. 2021. PMID: 33816702 Free PMC article.
-
Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation.Int J Mol Sci. 2021 Nov 18;22(22):12461. doi: 10.3390/ijms222212461. Int J Mol Sci. 2021. PMID: 34830342 Free PMC article.
-
Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement.Front Immunol. 2023 Jul 10;14:1166265. doi: 10.3389/fimmu.2023.1166265. eCollection 2023. Front Immunol. 2023. PMID: 37492582 Free PMC article.
-
Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction.Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F466-F479. doi: 10.1152/ajprenal.00116.2021. Epub 2021 Aug 23. Am J Physiol Renal Physiol. 2021. PMID: 34423679 Free PMC article.
References
-
- Asplund R Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999;84:297–301. - PubMed
-
- Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol. 1995;154:1764–9. - PubMed
-
- Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol. 1995;153:1510–5. - PubMed
-
- Teng J, Zhang D, Li Y, Yin L, Wang K, Cui X, et al. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int. 2013;111:312–23. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials